Breast Neoplasms: all 12,820 studies
Page 103 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- 4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast CancerCompletedNCT01626222Phase 3
- A Phase I Study of BKM120 in Adult Chinese Patients With Advanced Solid TumorsCompletedNCT01626209Phase 1
- Metabolizing Enzyme Genotype Versus Exemestane Metabolism ProfilesCompletedNCT01626144
- Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast CancerStatus unknownNCT01625429Phase 2
- Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast CancerCompletedNCT01624441Phase 1
- Bone Loss Treatment From Adjuvant Zoledronate EfficacyTerminatedNCT01623908Not applicable
- Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian CancerCompletedNCT01623349Phase 1
- Validity of Sentinel Lymphnode Biopsy After Neoadjuvant Chemotherapy Cancer Patients With Radiologically Positive Axillary Lymph NodesCompletedNCT01622478
- Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast CancerStatus unknownNCT01622361Phase 3
- Multidisciplinary Team IntervenTion in CArdio-ONcology (TITAN Study)Active, not recruitingNCT01621659Phase 2
- Assessing the Patient Experience in Cancer CareCompletedNCT01621295
- Study of ExAblate Focused Ultrasound Ablation of Breast CancerCompletedNCT01620359Phase 2
- Uncovering Potential Breast Cancer Biomarkers Amp; Possible Drug Targets Using Advanced Quantitative Mass SpectrometryStatus unknownNCT01619514
- Knowledge and Attitudes of Patients and Healthcare Professionals on a Spectrum of Genetic Tests Relevant to Breast Cancer PatientsStatus unknownNCT01619306
- DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCsCompletedNCT01619111Phase 3
- Pre-Operative Radiation and Veliparib for Breast CancerCompletedNCT01618357Phase 1
- PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence ScoreCompletedNCT01617954
- An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)CompletedNCT01615068
- Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated FertilityTerminatedNCT01614704
- Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast CancerWithdrawnNCT01614184Phase 1/2
- Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative EndocrinotherapyStatus unknownNCT01613560Phase 2
- TraStuzumAb-Radiotherapy : Impact on the Cerebral PreventionTerminatedNCT01613482Phase 3
- Feasibility of Ambulatory Surgery for Early Breast CancerCompletedNCT01613352Not applicable
- Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and SurgeryWithdrawnNCT01612910Phase 2
- Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast CancerCompletedNCT01612871Phase 4
- Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast CancerWithdrawnNCT01612728Phase 2
- Assessment of Substitution of Focused Cliches and Ultrasound for TomosynthesisCompletedNCT01612650Not applicable
- Interventions to Increase Screening by Breast Cancer Survivors and Their High Risk Female RelativesCompletedNCT01612338Not applicable
- Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant ChemotherapyStatus unknownNCT01612247Not applicable
- Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer PatientsCompletedNCT01611727Phase 2
- A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving ChemotherapyCompletedNCT01611051Phase 3
- A Phase I Study of LFA102 in Japanese PatientsCompletedNCT01610050Phase 1
- Nodal Staging in Breast Cancer With MRLTerminatedNCT01609920Not applicable
- Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast CancerStatus unknownNCT01609127Phase 2
- Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast CancerTerminatedNCT01608451Phase 3
- Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01606241Phase 1
- Perioperative Use of Desmopressin (DDAVP) in Breast CancerCompletedNCT01606072Phase 2
- Preventing Sexual Dysfunction With Aromatase InhibitorsCompletedNCT01603303Phase 2
- Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric CancerCompletedNCT01602406Phase 1
- Study the Usefulness of Bio-impedance Spectroscopy in the Early Assessment of Breast Cancer Related LymphoedemaCompletedNCT01599039
- An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)CompletedNCT01598597
- A Combined GWAS and miRNA for the Identification of Bevacizumab Response Predictors in Metastatic Breast CancerTerminatedNCT01598285
- A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric CancerCompletedNCT01598077Phase 1
- Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast CancerStatus unknownNCT01597999Phase 4
- A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast CancerTerminatedNCT01597921
- Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1CompletedNCT01597414Phase 2
- Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid TumorsCompletedNCT01596647Phase 1
- Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin TreatmentTerminatedNCT01596530Phase 1
- A Prospective Study to Evaluate the Effect of Systemic Adjuvant Therapy on the Cognitive Function of Breast Cancer PatientsStatus unknownNCT01596439
- Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung CancerCompletedNCT01594398Phase 1
- Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing ChemotherapyCompletedNCT01594177Phase 2
- Prospective Chart-Review: Impact of Combination - Digital Breast Tomosynthesis + Digital MammographyWithdrawnNCT01593384
- PiA: Prognosis Used Every Day for Patients With Operable Breast Cancer - Comparison of Invasion Factors uPA/PAI-1 With Other Prognostic FactorsStatus unknownNCT01592825
- A Randomized Controlled Mindfulness Based Stress Reduction Intervention in Women With Breast CancerStatus unknownNCT01591915Not applicable
- Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast CancerTerminatedNCT01589861Phase 1/2
- Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast CancerCompletedNCT01589367Phase 2
- A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or TaxanesCompletedNCT01589159Phase 2
- Use of Harmonic in Breast SurgeryCompletedNCT01587248Phase 3
- Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)CompletedNCT01583426Phase 3
- Exercise in Breast Cancer SurvivorsWithdrawnNCT01582685Not applicable
- The Ultrasound Study of TamoxifenCompletedNCT01582074
- National Breast Cancer and Lymphedema RegistryTerminatedNCT01580800
- Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) UsersActive, not recruitingNCT01579734Phase 3
- Reflexology: An Intervention for Advanced Breast CancerCompletedNCT01577420Not applicable
- Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsCompletedNCT01576666Phase 1
- Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall SurvivalCompletedNCT01574170Phase 4
- Effect of Concomitant Radiotherapy and Trastuzumab on Cardiotoxicity of Patients Treated for Early Breast CancerCompletedNCT01572883
- Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving SurgeryActive, not recruitingNCT01570998Not applicable
- A Comparison of Recall Rates Between Conventional 2d Mammography and 2d Plus 3d (Tomosynthesis) Mammography in a Screening PopulationStatus unknownNCT01569802
- Ohio Patient Navigator Research ProgramCompletedNCT01569672Not applicable
- Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility StudyTerminatedNCT01569321Not applicable
- Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision LumpectomyTerminatedNCT01568346Phase 3
- MR Characterisation/Localisation of Breast CancerCompletedNCT01567137
- HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1CompletedNCT01565200Phase 2
- Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine TreatmentCompletedNCT01564056Phase 3
- Support and Rehabilitation Protocol for Non Metastatic Breast Cancer Patients in Complete Remission After ChemotherapyTerminatedNCT01563588Not applicable
- Predictive Model of Therapy Outcomes in Breast Cancer PatientsCompletedNCT01563211
- Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without TrastuzumabCompletedNCT01562288
- LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast CancerCompletedNCT01561443
- Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast CancerActive, not recruitingNCT01560663
- Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer RiskCompletedNCT01559194Phase 3
- Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWithdrawnNCT01558778Not applicable
- A Mindfulness Meditation-Based Intervention for Younger Breast Cancer SurvivorsCompletedNCT01558258Phase 2
- Lapatinib With Trastuzumab in Treating Patients With HER2-Negative/HER2 Mutant Metastatic Breast CancerWithdrawnNCT01557764Phase 2
- Melatonin as Adjuvant Therapy in Breast Cancer PatientsStatus unknownNCT01557478Phase 2/3
- Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With AnthracyclinesCompletedNCT01555944
- Stress Management in Breast Cancer PatientsCompletedNCT01555645Not applicable
- Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer PatientsCompletedNCT01554943Phase 2
- Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or NotCompletedNCT01553903Phase 4
- Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive DifficultyCompletedNCT01553097
- Breast Cancer Recurrence - the Accuracy of Dual-time PET/CTCompletedNCT01552655Not applicable
- Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTerminatedNCT01552434Phase 1
- A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast CancerCompletedNCT01550848Phase 2
- Night-time Compression Systems for Breast Cancer Related LymphedemaCompletedNCT01550250Not applicable
- Efficacy Study of Herceptin to Treat HER2-negative CTC Breast CancerCompletedNCT01548677Phase 2
- A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast CancerTerminatedNCT01548534Phase 3
- Effects of a Dexmedetomidine on Quality of Recovery 40 and Postoperative Nausea and Vomiting in Breast Cancer SurgeryCompletedNCT01548209Not applicable
- Photography or Video in Assessing Breast Reconstruction?CompletedNCT01547338
- Tracking & Feedback Registry to Reduce Breast Cancer Treatment DisparitiesCompletedNCT01544374Not applicable
- Long Term Follow-up of Persistent Pain, Sensory Disturbances and Lymphedema After Breast Cancer TreatmentCompletedNCT01543711